Aposense granted the University of Pittsburgh a license to use its EarliTest imaging technology to research glioblastoma

Aposense Ltd.

Israel / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

University of Pittsburgh

U.S. / Academic

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced